New injection shows promise for lupus patients in early trial
NCT ID NCT06625671
First seen Dec 29, 2025 · Last updated May 08, 2026 · Updated 19 times
Summary
This study tests a new medicine, DB-2304, in healthy people and those with lupus (SLE or CLE). The goal is to check if it is safe and how the body processes it. About 148 adults will take part, and the study is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site AUS01-0
COMPLETEDMelbourne, Victoria, 3004, Australia
-
US02-0
RECRUITINGSan Antonio, Texas, 78215, United States
-
US03-0
RECRUITINGClearwater, Florida, 33765, United States
-
US04-0
RECRUITINGIrving, Texas, 75061, United States
Conditions
Explore the condition pages connected to this study.